COVID-19 is a novel viral disease, and there is no pre-existing immunity in our community. This project will target this need, through design and synthesis of nanoparticles-based antiviral materials and testing their efficiency on different surfaces. This project will involve the design and synthesis of a range of nanoparticles, their characterisation and immobilisation as well as investigation on their virus-killing properties on different surfaces.

Project members

Dr Nasim Amiralian

Group Leader
Amiralian Group

Professor Alan Rowan

AIBN Institute Director
Senior Group Leader
Rowan Group

Dr Jan Lauko

Postdoctoral researcher - Group Operations Manager
Rowan group

Divya Rajah

PhD Student
Rowan Group & Amiralian Group